Compare BKU & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BKU | EVO |
|---|---|---|
| Founded | 2009 | 1993 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 1.1B |
| IPO Year | 2011 | 2021 |
| Metric | BKU | EVO |
|---|---|---|
| Price | $45.13 | $2.94 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $42.36 | $7.00 |
| AVG Volume (30 Days) | ★ 1.0M | 137.3K |
| Earning Date | 01-21-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.72% | N/A |
| EPS Growth | ★ 44.85 | N/A |
| EPS | ★ 3.54 | N/A |
| Revenue | ★ $1,016,093,000.00 | $887,396,457.00 |
| Revenue This Year | $14.68 | N/A |
| Revenue Next Year | $5.73 | $8.80 |
| P/E Ratio | $12.85 | ★ N/A |
| Revenue Growth | ★ 10.45 | N/A |
| 52 Week Low | $28.21 | $2.84 |
| 52 Week High | $46.92 | $5.10 |
| Indicator | BKU | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 64.89 | 38.55 |
| Support Level | $45.33 | $2.94 |
| Resistance Level | $46.33 | $3.05 |
| Average True Range (ATR) | 0.94 | 0.10 |
| MACD | -0.11 | 0.01 |
| Stochastic Oscillator | 44.89 | 18.67 |
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.